Found: 5
Select item for more details and to access through your institution.
Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1693, doi. 10.3390/vaccines11111693
- By:
- Publication type:
- Article
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1184, doi. 10.3390/vaccines11071184
- By:
- Publication type:
- Article
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 570, doi. 10.3390/vaccines11030570
- By:
- Publication type:
- Article
Comparison of the reactogenicity and immunogenicity between two‐dose mRNA COVID‐19 vaccine and inactivated COVID‐19 vaccine followed by an mRNA vaccine in children aged 5−11 years.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 5, p. 1, doi. 10.1002/jmv.28758
- By:
- Publication type:
- Article
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42754-2
- By:
- Publication type:
- Article